Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (91-100 of 345) with videos related to

Pageof 35
Sort By:
The American Journal of Cardiology|September 28, 2019
Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction CategoriesIda Löfman, Karolina Szummer, Marie Evans, et al.
European Heart Journal|September 3, 2004
Natriuretic peptides in unstable coronary artery diseaseTomas Jernberg, Stefan James, Bertil Lindahl, et al.
The Lancet Regional Health. Europe|September 12, 2024
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTHans Christian Rosén, Moman A Mohammad, Tomas Jernberg, et al.
Cytokine|July 26, 2024
Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarctionSofia Cederström, Tomas Jernberg, Ann Samnegård, et al.
Journal of the American Heart Association|July 8, 2018
Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart FailureIda Löfman, Karolina Szummer, Henrik Olsson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 25, 2026
Clinical and Economic Outcomes Following First-Time Myocardial Infarction: A Nationwide Cohort Study from the SWEDEHEART RegistryChristian Reitan, Alexandre H Watanabe, Lori D Bash, et al.
Journal of the American College of Cardiology|April 25, 2015
Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART RegistryDina Melki, Johan Lugnegård, Joakim Alfredsson, et al.
Resuscitation|October 11, 2017
A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-scoreJonas Faxén, Marlous Hall, Chris P Gale, et al.
JACC. Heart Failure|March 7, 2015
Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008Liyew Desta, Tomas Jernberg, Ida Löfman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 4, 2025
Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort studyAli Yari, Carl-Emil Lim, Emil Hagström, et al.
Pageof 35

Showing results (91-100 of 345) with videos related to

Sort By:
Pageof 35
The American Journal of Cardiology|September 28, 2019
Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction CategoriesIda Löfman, Karolina Szummer, Marie Evans, et al.
European Heart Journal|September 3, 2004
Natriuretic peptides in unstable coronary artery diseaseTomas Jernberg, Stefan James, Bertil Lindahl, et al.
The Lancet Regional Health. Europe|September 12, 2024
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEARTHans Christian Rosén, Moman A Mohammad, Tomas Jernberg, et al.
Cytokine|July 26, 2024
Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarctionSofia Cederström, Tomas Jernberg, Ann Samnegård, et al.
Journal of the American Heart Association|July 8, 2018
Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart FailureIda Löfman, Karolina Szummer, Henrik Olsson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 25, 2026
Clinical and Economic Outcomes Following First-Time Myocardial Infarction: A Nationwide Cohort Study from the SWEDEHEART RegistryChristian Reitan, Alexandre H Watanabe, Lori D Bash, et al.
Journal of the American College of Cardiology|April 25, 2015
Implications of Introducing High-Sensitivity Cardiac Troponin T Into Clinical Practice: Data From the SWEDEHEART RegistryDina Melki, Johan Lugnegård, Joakim Alfredsson, et al.
Resuscitation|October 11, 2017
A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-scoreJonas Faxén, Marlous Hall, Chris P Gale, et al.
JACC. Heart Failure|March 7, 2015
Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008Liyew Desta, Tomas Jernberg, Ida Löfman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 4, 2025
Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort studyAli Yari, Carl-Emil Lim, Emil Hagström, et al.
Pageof 35